featured
Beneficial Effect of Oral Semaglutide for Type 2 Diabetes Mellitus in Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Beneficial effect of oral semaglutide for type 2 diabetes mellitus in patients with metabolic dysfunction-associated steatotic liver disease: A prospective, multicentre, observational study
Diabetes Obes Metab 2024 Sep 02;[EPub Ahead of Print], T Arai, M Atsukawa, A Tsubota, T Oikawa, T Tada, K Matsuura, T Ishikawa, H Abe, K Kato, A Morishita, J Tani, T Okubo, M Nagao, M Iwabu, K IwakiriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.